Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Baxter to make Moderna COVID-19 vaccine in US

By Chris Newmarker | March 9, 2021

Baxter ModernaBaxter announced that its Baxter BioPharma Solutions business will make Moderna‘s COVID-19 vaccine at its fill/finish sterile manufacturing facilities in Bloomington, Ind.

The plan — announced yesterday — is for Baxter to make 60–90 million doses of the Moderna vaccine in 2021.

“We have seen a remarkable demonstration of scientific and health care expertise in the effort to develop vaccines for COVID-19,” said Marie Keeley, VP of Baxter BioPharma Solutions.

“Baxter is honored to provide our deep expertise in vaccine manufacturing to help partners like Moderna bolster the supply of their vaccine,” Keeley said in a news release.

Baxter’s 600,000 ft2, 700-employee campus in Bloomington has capabilities and expertise in parenteral delivery systems and clinical and commercial vaccine manufacturing — including preventive and seasonal vaccines for global markets.

The major COVID-19 vaccine makers have been making a host of manufacturing outsourcing deals — sometimes with competitors — as they seek to ramp up production enough to meet U.S. and worldwide goals to reach herd immunity against the novel, potentially deadly coronavirus.

“This additional production will help us continue to scale up our manufacturing capacity in the United States,” Moderna CTO Juan Andres said of the deal with Baxter.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Catalent Biologics Madison Facility
Catalent expands biologics manufacturing facility in Wisconsin
Emergent Biosolutions
Emergent reportedly had serious problems at Baltimore vaccine plant
Johnson & Johnson
Feds put J&J in charge of vaccine production at Emergent plant
Johnson & Johnson
Factory error ruins 15M J&J COVID-19 vaccine doses

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards